Article Text

Download PDFPDF

High rates of depressive symptomatology among injecting drug users in Saskatoon, Canada

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.



What is the prevalence of depressive symptomatology among injecting drug users? Also, are there risk indicators of depressive symptomatology and is depressive symptomatology associated with HIV risk behaviours?


603 current injecting drug users (IDUs; defined as having injected a drug within the last 4 weeks) aged 18 years and older. IDUs were identified from a survey of 1000 people who were at risk of HIV either known current IDUs, current sex workers, men who had sex with other men or who used the services of sex workers. Participants were recruited from primary care clinics, needle exchange sites, AIDS Saskatoon, and a free meal facility. The sample comprised 76.6% of known IDUs in the Saskatoon Health Region.


Saskatoon Health Region, Canada; recruitment from September 2009 to April 2010.


Participants completed a survey, comprising 175 questions taken from validated questionnaires, measuring demographics, socioeconomic status and risk indicators (National Institute on Drug Abuse Risk Behaviours Assessment Questionnaire); depressive symptomatology (Center for …

View Full Text


  • Sources of funding Health Canada.


  • Competing interests None.